Education
About Us
Working with TipRanks
Follow Us
Renalytix (GB:RENX)
LSE:RENX
Total Valuation
Renalytix has a market cap or net worth of £25.13M. The enterprise value is 26.40M.
Market Cap£25.13M
Enterprise Value26.40M
Share Statistics
Renalytix has 437,018,680 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding437,018,680
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Renalytix’s return on equity (ROE) is 2.91 and return on invested capital (ROIC) is -1238.11%.
Return on Equity (ROE)2.91
Return on Assets (ROA)-3.34
Return on Invested Capital (ROIC)-1238.11%
Return on Capital Employed (ROCE)-13.23
Revenue Per Employee29.41K
Profits Per Employee-213.73K
Employee Count102
Asset Turnover0.49
Inventory Turnover9.00
Valuation Ratios
The current PE Ratio of Renalytix is ―. Renalytix’s PEG ratio is 0.01.
PE Ratio―
PS Ratio3.23
PB Ratio-1.38
Price to Fair Value-1.38
Price to FCF-0.54
Price to Operating Cash Flow-0.37
PEG Ratio0.01
Income Statement
In the last 12 months, Renalytix had revenue of 3.00M and earned -20.40M in profits. Earnings per share was -0.21.
Revenue3.00M
Gross Profit1.20M
Operating Income-17.20M
Pretax Income-21.80M
Net Income-20.40M
EBITDA-21.30M
Earnings Per Share (EPS)-0.21
Cash Flow
In the last 12 months, operating cash flow was -23.02M and capital expenditures -4.00K, giving a free cash flow of -23.02M billion.
Operating Cash Flow-23.02M
Free Cash Flow-23.02M
Free Cash Flow per Share-0.05
Dividends & Yields
Renalytix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.45
52-Week Price Change-45.24%
50-Day Moving Average6.29
200-Day Moving Average7.25
Relative Strength Index (RSI)27.03
Average Volume (3m)10.03M
Important Dates
Renalytix upcoming earnings date is Mar 26, 2026, TBA (Confirmed).
Last Earnings DateNov 26, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
Renalytix as a current ratio of 1.21, with Debt / Equity ratio of -108.67%
Current Ratio1.21
Quick Ratio1.17
Debt to Market Cap0.86
Net Debt to EBITDA-0.22
Interest Coverage Ratio-34.40
Taxes
In the past 12 months, Renalytix has paid -1.40M in taxes.
Income Tax-1.40M
Effective Tax Rate0.06
Enterprise Valuation
Renalytix EV to EBITDA ratio is -0.68, with an EV/FCF ratio of -0.80.
EV to Sales4.79
EV to EBITDA-0.68
EV to Free Cash Flow-0.80
EV to Operating Cash Flow-0.80
Balance Sheet
Renalytix has £9.63M in cash and marketable securities with £8.21M in debt, giving a net cash position of £1.42M billion.
Cash & Marketable Securities£9.63M
Total Debt£8.21M
Net Cash£1.42M
Net Cash Per Share<£0.01
Tangible Book Value Per Share-£0.07
Margins
Gross margin is 6.82%, with operating margin of -573.33%, and net profit margin of -680.00%.
Gross Margin6.82%
Operating Margin-573.33%
Pretax Margin-726.67%
Net Profit Margin-680.00%
EBITDA Margin-710.00%
EBIT Margin-710.00%
Analyst Forecast
The average price target for Renalytix is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-4.48%
EPS Growth Forecast61.09%